APA (7th ed.) Citation

Duflot, T., Tu, L., Leuillier, M., Messaoudi, H., Groussard, D., Feugray, G., . . . ANR-16-CE17-0012,SAPHIR,Impact de la modulation des activités enzymatiques de l'époxyde hydrolase soluble sur l'hypertension pulmonaire et la dysfonction ventriculaire droite lors de l'insuffisance cardiaque expérimentale et humaine(2016). (2021). Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension? ISSN: 2218-1989 ; Metabolites ; https://hal.science/hal-04532610 ; Metabolites, 2021, 11 (11), pp.784. ⟨10.3390/metabo11110784⟩. https://doi.org/10.3390/metabo11110784

Chicago Style (17th ed.) Citation

Duflot, Thomas, et al. "Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?" ISSN: 2218-1989 ; Metabolites ; Https://hal.science/hal-04532610 ; Metabolites, 2021, 11 (11), Pp.784. ⟨10.3390/metabo11110784⟩ 2021. https://doi.org/10.3390/metabo11110784.

MLA (9th ed.) Citation

Duflot, Thomas, et al. "Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?" ISSN: 2218-1989 ; Metabolites ; Https://hal.science/hal-04532610 ; Metabolites, 2021, 11 (11), Pp.784. ⟨10.3390/metabo11110784⟩, 2021, https://doi.org/10.3390/metabo11110784.